Protection against bronchial asthma by CFTR Δf508 mutation: A heterozygote advantage in cystic fibrosis

Nature Medicine

Volumn 1, Issue 7, 1995, Pages 703-705

  Schroeder, Scott A ^a   Gaughan, Denise M ^a   Swift, Michael ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; CHLORIDE; CYCLIC AMP; DNA; PHENYLALANINE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ALLELE; ARTICLE; ASTHMA; CHLORIDE CONDUCTANCE; CHROMOSOME; CYSTIC FIBROSIS; EXON; GENE; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELATIVE;

ADULT; ALLELES; ASTHMA; CYSTIC FIBROSIS; DISEASE SUSCEPTIBILITY; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMAN; MALE; MIDDLE AGE; NEW YORK; POINT MUTATION; PREVALENCE; SELECTION (GENETICS);

EID: 0029016718     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0795-703     Document Type: Article

References (15)

1. Tizzano, E.F. and Buchwald, M. Cystic fibrosis: Beyond the gene to therapy. J. Pe- diat. 120, 337-349 (1992).
2. Lemna, W.K. et al. Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. New Engl. J. Med. 322, 291-296 (1990).
3. Monal, N. et al. The origin of the major cystic fibrosis mutation (AF508) in European populations. Nature Genet. 1, 169-175 (1994).
4. Davis, P.B. and Vargo, K. Pulmonary abnormalities in obligate heterozygotes for cystic fibrosis. Thorax 42, 120-125 (1987).
5. Davis, P.B. and Byard, P.J. Heterozygotes for cystic fibrosis: Models for study of airway and autonomic reactivity. J. appl. Physiol. 66, 2124-2128 (1989).
6. Gyurkovitz, K., Markus, V. and Bittera, I. Cystic fibrosis heterozygosity in childhood bronchial asthma. Lancet 1, 203 (1977).
7. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. resp. Dis. 136, 225-244 (1977).
8. National Asthma Education Program. Guidelines for the diagnosis and management of asthma. (National Institutes of Health, Bethesda, MD, 1991. DHMS publication no. NIH 91-3042).
9. Swift, M., Küpper, L.L. and Chase, C.L. Effective testing of gene-disease associations. Am. J. hum. Genet. 47, 266-274 (1990).
10. Pignatti, P.F., Bombieri, C., Marigo, C., Benetazzo, M. and Luisetti, M. Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis. Hum. molec. Genet 4, 635-639 (1995).
11. Counahan, R. and Meams, M.B. Prevalence of atopy and exercise-induced bronchial lability in relatives of patients with cystic fibrosis. Archs Dis. Childh. 50, 477-481 (1975).
12. Bonforte, R.J. Pneumonia of infancy, in Pediatric Respiratory Disease (ed. Hilman, B.) Ch. 30, p. 263 (Saunders, Philadelphia, 1993).
13. Baxter, P.S., Goldhill, J., Hardcastle, J., Hardcastle, P.T. and Taylor, C.J. Accounting for cystic fibrosis. Nature 335, 211 (1988).
14. Quinton PM. Cystic fibrosis: A disease in electrocyte transport. FASEB J. 4, 2709-2717 (1990).
15. Friedman, K.J., Highsmith, W.E. and Silverman, L.M. Detecting multiple cystic fibrosis mutations by polymerase chain reaction-mediated site-directed mutagenesis. Clin. Chem. 37, 753-755 (1991).